Group structure
2 companies in 2 countries
Canada1
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
16 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTIKERALL0.5 % / w/w + 10 % / w/w · Solution | Fluorouracil, Salicylic acid | Canada | Marketed | 2016 |
| AGGRASTAT12.5 mg / 250 ml · Solution | Tirofiban | Canada | Marketed | 2002 |
| BRINAVESS20 mg / ml · Solution | Vernakalant | Canada | Marketed | 2018 |
| CONZIP100mg | 150mg | 200mg | 300mg · Capsule, extended release | Tramadol | United States | Marketed | 2010 |
| DURELA300 mg · Capsule (Extended-Release) | Tramadol | Canada | Marketed | 2012 |
| DURELA200 mg · Capsule (Extended-Release) | Tramadol | Canada | Marketed | 2012 |
| DURELA100 mg · Capsule (Extended-Release) | Tramadol | Canada | Marketed | 2012 |
| EPURIS20 mg · Capsule | Isotretinoin | Canada | Marketed | 2013 |
| EPURIS40 mg · Capsule | Isotretinoin | Canada | Marketed | 2013 |
| EPURIS10 mg · Capsule | Isotretinoin | Canada | Marketed | 2013 |
| EPURIS30 mg · Capsule | Isotretinoin | Canada | Marketed | 2013 |
| LIPOFEN100mg | 150mg | 50mg · Capsule | Fenofibrate | United States | Marketed | 2006 |
| NATROBA0.9% · Suspension | Spinosad | United States | Marketed | 2011 |
| VANIQA13.9 % / w/w · Cream | Eflornithine | Canada | Marketed | 2005 |
| FENOMAX100 mg · Capsule | Fenofibrate | Canada | Cancelled | |
| FENOMAX160 mg · Capsule | Fenofibrate | Canada | Cancelled | 2006 |